Epithelial to mesenchymal transition (EMT) induced by bleomycin or TFG b1/EGF in murine induced pluripotent stem cell-derived alveolar Type II-like cells

Differentiation

Volumn 82, Issue 2, 2011, Pages 89-98

  Alipio, Zaida A ^a   Jones, Nathan ^a   Liao, Wenbin ^e   Yang, Jianchang ^a   Kulkarni, Shilpa ^b   Sree Kumar, K ^b   Hauer Jensen, Martin ^c   Ward, David C ^d   Ma, Yupo ^e   Fink, Louis M ^a  

^a NEVADA CANCER INSTITUTE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

Alveolar Type II cells; Bleomycin; EMT; Epithelial to mesenchymal transition; IPS cells; TGF b1 EGF

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; CALVASCULIN; COLLAGEN TYPE 1; COMPLEMENT COMPONENT C3; EPIDERMAL GROWTH FACTOR; LIPID; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; FILOPODIUM; IMMUNOFLUORESCENCE; LAMELLAR BODY; LUNG ALVEOLUS CELL TYPE 2; MESENCHYME CELL; MOUSE; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; SUPERNATANT; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION;

ANIMALS; BLEOMYCIN; COMPLEMENT C3; EPIDERMAL GROWTH FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; INDUCED PLURIPOTENT STEM CELLS; LUNG; LUNG DISEASES; MICE; MICE, INBRED C57BL; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; SKIN; TRANSFORMING GROWTH FACTOR BETA1;

IPS; MURINAE; MUS;

EID: 80051564941     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2011.05.001     Document Type: Article

References (27)

1. Alipio Z., Liao W., Roemer E.J., Waner M., Fink L.M., Ward D.C., Ma Y. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc. Natl. Acad. Sci. USA 2010, 107:13426-13431.
2. Andrews P.W. From teratocarcinomas to embryonic stem cells. Philos. Trans. R. Soc. London B Biol. Sci. 2002, 357:405-417.
3. Bodnar M.S., Meneses J.J., Rodriguez R.T., Firpo M.T. Propagation and maintenance of undifferentiated human embryonic stem cells. Stem Cells Dev. 2004, 13:243-253.
4. Boyer B., Roche S., Denoyelle M., Thiery J.P. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J. 1997, 16:5904-5913.
5. Brabletz T., Jung A., Hermann K., Gunther K., Hohenberger W., Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol. Res. Pract. 1998, 194:701-704.
6. Chen H., Fernig D.G., Rudland P.S., Sparks A., Wilkinson M.C., Barraclough R. Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem. Biophys. Res. Commun. 2001, 286:1212-1217.
7. Coraux C., Nawrocki-Raby B., Hinnrasky J., Kileztky C., Gaillard D., Dani C., Puchelle E. Embryonic stem cells generate airway epithelial tissue. Am. J. Respir. Cell Mol. Biol. 2005, 32:87-92.
8. Gal A., Sjoblom T., Fedorova L., Imreh S., Beug H., Moustakas A. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 2008, 27:1218-1230.
9. Hanna J., Wernig M., Markoulaki S., Sun C.W., Meissner A., Cassady J.P., Beard C., Brambrink T., Wu L.C., Townes T.M., Jaenisch R. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318:1920-1923.
10. Illman S.A., Lehti K., Keski-Oja J., Lohi J. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J. Cell Sci. 2006, 119:3856-3865.
11. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112:1776-1784.
12. Manotham K., Tanaka T., Matsumoto M., Ohse T., Inagi R., Miyata T., Kurokawa K., Fujita T., Ingelfinger J.R., Nangaku M. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int. 2004, 65:871-880.
13. Ohtsuka S., Dalton S. Molecular and biological properties of pluripotent embryonic stem cells. Gene Ther. 2008, 15:74-81.
14. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
15. Piek E., Moustakas A., Kurisaki A., Heldin C.H., ten Dijke P. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci. 1999, 112(Pt 24):4557-4568.
16. Rippon H.J., Lane S., Qin M., Ismail N.S., Wilson M.R., Takata M., Bishop A.E. Embryonic stem cells as a source of pulmonary epithelium in vitro and in vivo. Proc. Am. Thorac. Soc. 2008, 5:717-722.
17. Rippon H.J., Polak J.M., Qin M., Bishop A.E. Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a three-step differentiation protocol. Stem Cells 2006, 24:1389-1398.
18. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
19. Uttamsingh S., Bao X., Nguyen K.T., Bhanot M., Gong J., Chan J.L., Liu F., Chu T.T., Wang L.H. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 2008, 27:2626-2634.
20. Wang D., Haviland D.L., Burns A.R., Zsigmond E., Wetsel R.A. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2007, 104:4449-4454.
21. Wang X., Nie J., Zhou Q., Liu W., Zhu F., Chen W., Mao H., Luo N., Dong X., Yu X. Downregulation of Par-3 expression and disruption of Par complex integrity by TGF-beta during the process of epithelial to mesenchymal transition in rat proximal epithelial cells. Biochim. Biophys. Acta 2008, 1782:51-59.
22. Wang Y.V., Wade M., Wong E., Li Y.C., Rodewald L.W., Wahl G.M. Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation. Proc. Natl. Acad. Sci. USA 2007, 104:12365-12370.
23. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
24. Wishart T.M., Paterson J.M., Short D.M., Meredith S., Robertson K.A., Sutherland C., Cousin M.A., Dutia M.B., Gillingwater T.H. Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene. Mol. Cell Proteomics 2007, 6:1318-1330.
25. Xu D., Alipio Z., Fink L.M., Adcock D.M., Yang J., Ward D.C., Ma Y. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc. Natl. Acad. Sci. USA 2009, 106:808-813.
26. Yamamoto T., Eckes B., Krieg T. Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts. Arch. Dermatol. Res. 2000, 292:556-561.
27. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119:1429-1437.